PJECX | VGSNX | PJECX / VGSNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 21 years | - |
Gain YTD | 16.954 | 13.720 | 124% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 129M | 71.5B | 0% |
Annual Yield % from dividends | 1.03 | 4.01 | 26% |
Returns for 1 year | 31.06 | 33.28 | 93% |
Returns for 3 years | -4.10 | 3.20 | -128% |
Returns for 5 years | 13.79 | 24.60 | 56% |
Returns for 10 years | 25.83 | 83.39 | 31% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 27.36 | 0.39 | +1.43% |
iShares Neuroscience and Healthcare ETF | |||
SAGP | 30.07 | 0.07 | +0.23% |
Strategas Global Policy Opp ETF | |||
UOCT | 35.02 | 0.07 | +0.19% |
Innovator U.S. Equity Ultra Buf ETF™ Oct | |||
JPIE | 46.05 | 0.04 | +0.09% |
JPMorgan Income ETF | |||
HTAB | 19.74 | N/A | N/A |
Hartford Schroders Tax-Aware Bond ETF |